Cargando…

Corrigendum: Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review

Detalles Bibliográficos
Autores principales:	Leere, Julius Simoni, Karmisholt, Jesper, Robaczyk, Maciej, Vestergaard, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517393/ https://www.ncbi.nlm.nih.gov/pubmed/28740484 http://dx.doi.org/10.3389/fendo.2017.00172

Ejemplares similares

Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review
por: Leere, Julius Simoni, et al.
Publicado: (2017)

Associations between trabecular bone score and biochemistry in surgically vs conservatively treated outpatients with primary hyperparathyroidism: A retrospective cohort study
por: Leere, Julius Simoni, et al.
Publicado: (2018)

Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level
por: Chertok Shacham, Elena, et al.
Publicado: (2023)

Effects of bendroflumethiazide on bone mineral density; results from the BONATHIAD randomized double-blind placebo-controlled cohort study
por: Emmanuel, Thomas, et al.
Publicado: (2020)

The Russian registry of primary hyperparathyroidism, latest update
por: Mokrysheva, Natalia G., et al.
Publicado: (2023)

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
por: Di Dalmazi, Giulia, et al.
Publicado: (2018)

The TRH test provides valuable information in the diagnosis of central hypothyroidism in patients with known pituitary disease and low T4 levels
por: Christensen, Sara Ellegaard, et al.
Publicado: (2023)

The Impact of Moderate Hypophosphatemia on the Clinical Management of Primary Hyperparathyroidism
por: Güneş, Elif, et al.
Publicado: (2023)

Medical management of primary hyperparathyroidism
por: Bandeira, Francisco, et al.
Publicado: (2022)

Familial Hyperparathyroidism
por: Blau, Jenny E., et al.
Publicado: (2021)

Diabetes and Bone Involvement in Primary Hyperparathyroidism: Literature Review and Our Personal Experience
por: Castellano, Elena, et al.
Publicado: (2021)

Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis
por: Rajput, Swati, et al.
Publicado: (2023)

Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing
por: Park, Hye-Sun, et al.
Publicado: (2022)

The effects of season (spring versus autumn) on diagnosis of normocalcemic primary hyperparathyroidism
por: Basińska-Lewandowska, Magdalena, et al.
Publicado: (2022)

The preliminary study on cardiac structure and function in Chinese patients with primary hyperparathyroidism
por: Chen, Rong, et al.
Publicado: (2023)

Predicting multigland disease in primary hyperparathyroidism using ultrasound and clinical features
por: Luo, Yanwen, et al.
Publicado: (2023)

Cinacalcet use in secondary hyperparathyroidism: a machine learning-based systematic review
por: Li, Xiaosong, et al.
Publicado: (2023)

Successful parathyroidectomy improves cognition in patients with primary hyperparathyroidism: A prospective study in a tertiary medical center and comprehensive review of the literature
por: Szalat, Auryan, et al.
Publicado: (2022)

Primary Hyperparathyroidism in Pregnancy - Two Case Reports
por: Mehta, Anku, et al.
Publicado: (2021)

Hip Fracture in a Patient with Primary Hyperparathyroidism: Medical and Surgical Lessons
por: Baig, MN, et al.
Publicado: (2018)

SAT-232 Is There a Role for Genetic Testing in Guiding the Management of Primary Hyperparathyroidism in Pregnancy?
por: McCarthy, Aisling, et al.
Publicado: (2019)

The Associations of Serum Osteocalcin and Cortisol Levels With the Psychological Performance in Primary Hyperparathyroidism Patients
por: Wang, Shu-min, et al.
Publicado: (2021)

Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism
por: Ni, Wenjing, et al.
Publicado: (2021)

Association of Famine Exposure on the Changing Clinical Phenotypes of Primary Hyperparathyroidism in 20 years
por: Yuan, Tian-jiao, et al.
Publicado: (2022)

Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment
por: Kuo, Yu-Chi, et al.
Publicado: (2023)

Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience
por: Dobreva, Ekaterina A., et al.
Publicado: (2023)

Improvement of hypertension control and left-ventricular function after cure of primary hyperparathyroidism
por: Karwacka, Izabela, et al.
Publicado: (2023)

Recurrent Primary Hyperparathyroidism in Hyperparathyroid Jaw Tumor Syndrome: A Case Report
por: Kang, James R, et al.
Publicado: (2023)

Masked Primary Hyperparathyroidism by Empagliflozin Use
por: Awada, Mariam, et al.
Publicado: (2022)

When Parathyroidectomy Should Be Indicated or Postponed in Adolescents With MEN1-Related Primary Hyperparathyroidism
por: Marini, Francesca, et al.
Publicado: (2018)

Development and validation of a nomogram for risk prediction of nephrolithiasis recurrence in patients with primary hyperparathyroidism
por: Zhou, Yihong, et al.
Publicado: (2022)

Comparison of biochemical markers and technetium 99m methoxyisobutylisonitrile imaging in primary and secondary hyperparathyroidism
por: Wang, Yuhua, et al.
Publicado: (2023)

A Clinical Review of the Psychiatric Sequelae of Primary Hyperparathyroidism
por: Serdenes, Ryan, et al.
Publicado: (2021)

A Delicate Balance: Challenges in the Management of Primary Hyperparathyroidism and Congestive Heart Failure
por: Mohan, Nikita, et al.
Publicado: (2023)

Advances in the treatment of secondary and tertiary hyperparathyroidism
por: Zhang, Li-Xi, et al.
Publicado: (2022)

Treatment for secondary hyperparathyroidism focusing on parathyroidectomy
por: Hiramitsu, Takahisa, et al.
Publicado: (2023)

Single-cell RNA sequencing reveals the role of cell heterogeneity in the sex difference in primary hyperparathyroidism
por: Lu, Shuai, et al.
Publicado: (2023)

Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China
por: Lin, Xiaoyun, et al.
Publicado: (2021)

LBSAT309 Recurrent Nephrolithiasis As A Presenting Feature Of Primary Hyperparathyroidism
por: Patel, Toral, et al.
Publicado: (2022)

25-Hydroxyvitamin D and Vitamin D Binding Protein Levels in Patients With Primary Hyperparathyroidism Before and After Parathyroidectomy
por: Wang, Xiangbing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1vividaud004rqben7k3talfjl